Stocktoria
OmniAb, Inc. OABI
Nasdaq · XNAS · stock · Services-Commercial Physical & Biological Research · website · IPO 2020-10-09
OmniAb, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $18.7M | $26.4M | $34.2M | $59.1M | $34.7M |
| R&D expense | $47.8M | $55.1M | $56.5M | $48.4M | $39.2M |
| Operating income | -$69.0M | -$74.5M | -$69.4M | -$26.6M | -$35.6M |
| Interest expense | — | — | — | $0 | $7,000 |
| Income tax | -$1.5M | -$9.4M | -$13.7M | -$3.7M | -$7.3M |
| Net income | -$64.8M | -$62.0M | -$50.6M | -$22.3M | -$27.0M |
| EPS (diluted) | $-0.57 | $-0.61 | $-0.51 | $-0.26 | $-0.33 |
| Operating cash flow | -$36.5M | -$39.7M | $2.3M | -$3.6M | -$5.7M |
| Free cash flow | -$37.0M | -$41.5M | $703,000 | -$20.8M | -$9.7M |
| Cash & equivalents | $25.5M | $27.6M | $16.4M | $33.4M | $0 |
| Inventory | $823,000 | $48,000 | — | — | — |
| Total assets | $300.9M | $325.6M | $375.2M | $421.2M | $304.5M |
| Total liabilities | $33.9M | $37.9M | $60.6M | $79.8M | $70.2M |
| Shareholders' equity | $267.0M | $287.6M | $314.6M | $341.4M | $234.3M |
Source: SEC EDGAR filings · CIK 0001846253 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.